Clincosm LogoSign in Get a demo

pancreatic cancer

Showing NaN - NaN of 102
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, PDAC Trial in Boston (other, diagnostic test, combination product)

Not yet recruiting
  • Pancreatic Cancer
  • +4 more
  • Screening Blood Tests
  • +3 more
  • Boston, Massachusetts
  • +1 more
Nov 3, 2023

Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma Trial in Boston (Zentalis, Gemzar)

Not yet recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
  • +1 more
Aug 23, 2023

Breast Cancer, Ovarian Cancer, Pancreatic Cancer Trial in United States (Standard Genetic Counseling, Educational Video)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Standard Genetic Counseling
  • Educational Video
  • Boston, Massachusetts
  • +5 more
Jan 25, 2023

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)

Completed
Has Results
  • Pancreatic Cancer
  • +2 more
  • AMG820 and pembrolizumab
  • Atlanta, Georgia
  • +14 more
Jan 18, 2023

Pancreatic Cancer, Hepatocellular Cancer, Squamous Cell Cancer (SCC) Trial in United States (TAK-500, Pembrolizumab)

Recruiting
  • Pancreatic Cancer
  • +9 more
  • Duarte, California
  • +6 more
Jan 17, 2023

Pancreatic Cancer, Pancreas Cancer, Pancreatic Diseases Trial in Canada, United States (Cefoxitin, Piperacillin-tazobactam)

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Sacramento, California
  • +31 more
Jan 12, 2023

Pancreatic Cancer Trial in Boston, Philadelphia (Gemcitabine, Nab-paclitaxel, Paricalcitol)

Active, not recruiting
  • Pancreatic Cancer
  • Boston, Massachusetts
  • +1 more
Jan 9, 2023

Pancreatic Cancer, Adenocarcinoma of the Pancreas, Squamous Cell Carcinoma of Pancreas Trial in Boston (ZIMBERELIMAB,

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 9, 2023

Lung Cancer Squamous Cell, Solid Tumors, Head & Neck Cancer Trial in Boston (Palbociclib, Gedatolisib)

Recruiting
  • Lung Cancer Squamous Cell
  • +3 more
  • Boston, Massachusetts
  • +2 more
Jan 9, 2023

Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

Recruiting
  • Pancreatic Adenocarcinoma Metastatic
  • +14 more
  • Boston, Massachusetts
  • +1 more
Dec 6, 2022

Advanced Pancreatic Ductal Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer Trial in Boston (AGEN1423,

Not yet recruiting
  • Advanced Pancreatic Ductal Adenocarcinoma
  • +2 more
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Nov 18, 2022

Pancreatic Cancer, Esophageal Cancer, Gastric Cancer Trial in Boston (Usual Care, Perioperative Geriatrics Intervention)

Completed
  • Pancreatic Cancer
  • +5 more
  • Usual Care
  • Perioperative Geriatrics Intervention
  • Boston, Massachusetts
    Massachusetts general Hospital
Nov 18, 2022

Pancreatic Cancer, GastroEsophageal Cancer, Rectal Cancer Trial in Boston (Supportive Oncology Care at Home, Usual Care)

Recruiting
  • Pancreatic Cancer
  • +3 more
  • Supportive Oncology Care at Home
  • Usual Care
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 18, 2022

Advanced Solid Tumor, Gynecologic Cancer, Breast Cancer Trial in United States (PY159 Single agent dose level 1, PY159 Single

Recruiting
  • Advanced Solid Tumor
  • +7 more
  • PY159 Single agent dose level 1
  • +17 more
  • San Francisco, California
  • +11 more
Nov 3, 2022

Genetic Testing, Breast Cancer, Ovarian Cancer Trial in Boston (Video Education, Genetic Counseling)

Recruiting
  • Genetic Testing
  • +8 more
  • Video Education
  • Genetic Counseling
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Oct 31, 2022

Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Boston, Massachusetts
  • +1 more
Sep 16, 2022

Advanced Solid Tumor, Breast Cancer, Small-cell Lung Cancer Trial in United States (SY-5609, Fulvestrant, Gemcitabine)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Gilbert, Arizona
  • +16 more
Sep 13, 2022

Pancreatic Cancer Trial in United States (drug, radiation, procedure)

Active, not recruiting
  • Pancreatic Cancer
  • Aurora, Colorado
  • +9 more
Sep 7, 2022

Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Nivolumab, Ipilimumab, Radiation)

Active, not recruiting
  • Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Boston, Massachusetts
  • +2 more
Sep 7, 2022

Biomarkers in Subjects With Untreated Solid Tumors

Completed
  • Breast Cancer
  • +12 more
  • Blood Sample Collection
  • Phoenix, Arizona
  • +118 more
Aug 31, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

Available
  • Non Small Cell Lung Cancer
  • +6 more
  • Goodyear, Arizona
  • +67 more
Aug 17, 2022

Colorectal Cancer, Pancreatic Cancer, Esophageal Cancer Trial in Boston (LUM015, LUM 2.6 Imaging Device)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Aug 15, 2022

NSCLC, Renal Cell Cancer, Colorectal Cancer Trial in Australia, United States (CPI-006, CPI-006 + ciforadenant, CPI-006 +

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +12 more
  • Tucson, Arizona
  • +26 more
Aug 1, 2022

Pancreatic Cancer Trial in Boston (Resistance Training (RT) and Protein Supplementation (PS), Resistance Training (RT),

Not yet recruiting
  • Pancreatic Cancer
  • Resistance Training (RT) and Protein Supplementation (PS)
  • +2 more
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Apr 29, 2022